(Q52016846)

19 April 2018

title

Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing. (English)

1 reference

19 April 2018

0 references

Vardit Kram

1

1 reference

19 April 2018

Tamar Peretz

series ordinal

2

1 reference

19 April 2018

Michal Sagi

series ordinal

3

1 reference

19 April 2018

publication date

25 May 2006

1 reference

19 April 2018

published in

Familial Cancer

1 reference

19 April 2018

volume

5

1 reference

19 April 2018

issue

4

1 reference

19 April 2018

page(s)

327-335

1 reference

19 April 2018

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

cites work

1 reference

12 December 2020

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

1 reference

12 December 2020

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing

1 reference

12 December 2020

Clinical options for women at high risk for breast cancer

1 reference

12 December 2020

Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes.

1 reference

12 December 2020

What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination

1 reference

12 December 2020

Cancer risks in BRCA2 mutation carriers

1 reference

12 December 2020

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

12 December 2020

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

1 reference

12 December 2020

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

1 reference

12 December 2020

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort

1 reference

12 December 2020

Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention

1 reference

12 December 2020

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

12 December 2020

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

12 December 2020

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

1 reference

12 December 2020

Prophylactic mastectomy or screening in women suspected to have the BRCA1/2 mutation: a prospective pilot study of women's treatment choices and medical and decision-analytic recommendations

1 reference

12 December 2020

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

1 reference

12 December 2020

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey

1 reference

12 December 2020

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

12 December 2020

Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines

1 reference

12 December 2020

Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.

1 reference

12 December 2020

Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?

1 reference

12 December 2020

The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction

1 reference

12 December 2020

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

12 December 2020

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

12 December 2020

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

1 reference

12 December 2020

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy

1 reference

12 December 2020

Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation

1 reference

12 December 2020

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women

1 reference

12 December 2020

What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations

1 reference

12 December 2020

Familial cancer: implications for surgical management of high-risk patients

1 reference

12 December 2020

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

12 December 2020

Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group

1 reference

12 December 2020

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis

1 reference

12 December 2020

Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women?

1 reference

12 December 2020

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women

1 reference

12 December 2020

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

1 reference

12 December 2020

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

12 December 2020

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling

1 reference

12 December 2020

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

10.1007/S10689-006-0002-Z

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018